v3.26.1
Note 14 - US Warrants (Details Textual)
$ / shares in Units, $ in Thousands
 10 Months Ended 12 Months Ended
Dec. 31, 2025
Apr. 14, 2025
$ / shares
Apr. 03, 2025
$ / shares
Oct. 22, 2025
$ / shares
Dec. 31, 2025
CAD ($)
$ / shares
Dec. 31, 2024
CAD ($)
Dec. 31, 2023
CAD ($)
Statement Line Items [Line Items]              
Gain (loss) on designation of financial instrument as measured at fair value through profit or loss because credit derivative is used to manage credit risk         $ 74,410 $ 7 $ 1,243
The 2026 warrants [member]              
Statement Line Items [Line Items]              
Number of other equity instruments granted in share-based payment arrangement   3,125,000     3,125,000    
Expected volatility, other equity instruments granted   85.00%          
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares         $ 1.11    
Risk free interest rate, other equity instruments granted 2.55%            
Gain (loss) on designation of financial instrument as measured at fair value through profit or loss because credit derivative is used to manage credit risk         $ 8,112    
The 2026 warrants [member] | Bottom of range [member]              
Statement Line Items [Line Items]              
Expected volatility, other equity instruments granted   125.00% 61.79%        
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares   $ 1.37 $ 1.38        
Risk free interest rate, other equity instruments granted   2.38% 2.40%        
The 2026 warrants [member] | Top of range [member]              
Statement Line Items [Line Items]              
Expected volatility, other equity instruments granted   127.60% 121.59%        
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares   $ 6.55 $ 1.5        
Risk free interest rate, other equity instruments granted   2.48% 2.58%        
Pre-funded warrants [member]              
Statement Line Items [Line Items]              
Number of other equity instruments granted in share-based payment arrangement         31,735,657    
Gain (loss) on designation of financial instrument as measured at fair value through profit or loss because credit derivative is used to manage credit risk         $ (36,698)    
New equity offering warrants [member]              
Statement Line Items [Line Items]              
Number of other equity instruments granted in share-based payment arrangement         46,000,000    
Expected volatility, other equity instruments granted       87.00% 90.00%    
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares       $ 2.31 $ 1.11    
Risk free interest rate, other equity instruments granted       2.39% 2.81%    
Gain (loss) on designation of financial instrument as measured at fair value through profit or loss because credit derivative is used to manage credit risk         $ (46,006)    
The 2028 warrants [member]              
Statement Line Items [Line Items]              
Gain (loss) on designation of financial instrument as measured at fair value through profit or loss because credit derivative is used to manage credit risk         $ 182